Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation. | Elife | 2022 | 36259537 | PubTator, text mining | PubMed |
| AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors. | Oncogene | 2022 | 36241868 | PubTator, text mining | PubMed |
| Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC. | Cells | 2022 | 36231025 | PubTator, text mining | PubMed |
| Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1). | Cells | 2022 | 36230978 | PubTator, text mining | PubMed |
| High Hemin Concentration Induces Escape from Senescence of Normoxic and Hypoxic Colon Cancer Cells. | Cancers (Basel) | 2022 | 36230727 | PubTator, text mining | PubMed |
| The interferon-inducible protein viperin controls cancer metabolic reprogramming to enhance cancer progression. | J Clin Invest | 2022 | 36227691 | PubTator, text mining | PubMed |
| STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth. | J Exp Clin Cancer Res | 2022 | 36217202 | PubTator, text mining | PubMed |
| A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses. | Commun Biol | 2022 | 36207580 | PubTator, text mining | PubMed |
| A multifaceted evaluation of microgliosis and differential cellular dysregulation of mammalian target of rapamycin signaling in neuronopathic Gaucher disease. | Front Mol Neurosci | 2022 | 36204141 | PubTator, text mining | PubMed |
| Construction of a Prognosis Model of the Pyroptosis-Related Gene in Multiple Myeloma and Screening of Core Genes. | ACS Omega | 2022 | 36188246 | PubTator, text mining | PubMed |
| Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer. | J Biol Chem | 2022 | 36183837 | PubTator, text mining | PubMed |
| Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis. | Neurosurg Focus | 2022 | 36183176 | PubTator, text mining | PubMed |
| Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma. | Sci Adv | 2022 | 36170375 | PubTator, text mining | PubMed |
| Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism. | ACS Synth Biol | 2022 | 36169352 | PubTator, text mining | PubMed |
| Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics. | Int J Mol Sci | 2022 | 36142502 | PubTator, text mining | PubMed |
| Overexpressing eukaryotic elongation factor 1 alpha (eEF1A) proteins to promote corticospinal axon repair after injury. | Cell Death Discov | 2022 | 36123349 | PubTator, text mining | PubMed |
| Ti3 C2 Tx MXene Composite 3D Hydrogel Potentiates mTOR Signaling to Promote the Generation of Functional Hair Cells in Cochlea Organoids. | Adv Sci (Weinh) | 2022 | 36117048 | PubTator, text mining | PubMed |
| Transcriptional and Immune Landscape of Cardiac Sarcoidosis. | Circ Res | 2022 | 36111531 | PubTator, text mining | PubMed |
| Brain-restricted mTOR inhibition with binary pharmacology. | Nature | 2022 | 36104566 | PubTator, text mining | PubMed |
Rotavirus Downregulates Tyrosine Hydroxylase in the Noradrenergic Sympathetic Nervous System in Ileum, Early in Infection and Simultaneously with Increased Intestinal Transit and Altered Brain Activities. | mBio | 2022 | 36094089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=18